Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data

A Southwest Florida ophthalmology practice has released internal outcomes data indicating that patients receiving the Light Adjustable Lens (LAL) during cataract surgery achieved refractive precision surpassing published national averages across multiple measures. Frantz EyeCare, a multispecialty practice based in Fort Myers, Florida, reported the figures in a press release, describing results that the practice contends reflect both the technology's capabilities and its clinical implementation.¹

While the data are single-center and not peer-reviewed, they contribute to the broader clinical conversation surrounding postoperative refractive accuracy in premium cataract surgery—an area of growing importance as patient expectations for spectacle independence continue to rise.

What refractive outcomes did Frantz EyeCare report with the LAL?

According to the press release, Frantz EyeCare's LAL outcomes included 98% of patients achieving a manifest refraction spherical equivalent (MRSE) within ±0.50 diopters (D) of target, compared with a reported national average of 94%.¹ For astigmatism correction, 96% of patients landed within ±0.50 D of cylinder target, versus a national average of 92%. Sphere accuracy within ±0.50 D was achieved in 97% of patients.¹

The practice also cited a comparison against a retrospective study by Doane and colleagues, which reportedly found that traditional toric intraocular lenses achieved the tightest measure of astigmatic precision in approximately half of patients, while the LAL achieved this threshold in 76%.¹ Frantz EyeCare reported a rate of 96% for the same metric in its own cohort. The Doane study is referenced by the practice but was not independently verified for this report; readers should consult the primary literature directly.

"The Light Adjustable Lens lets us fine-tune each patient's vision after surgery, so the result isn't just close, it's customized to them," said Jonathan M. Frantz, MD, FACS, medical director and chief surgeon of Frantz EyeCare. "Better technology means better outcomes, and these numbers show it."¹

How does the Light Adjustable Lens differ from conventional IOLs?

The LAL is a photosensitive silicone intraocular lens implanted during standard cataract surgery that allows postoperative refractive adjustment through ultraviolet light treatments administered in the clinic.² Unlike conventional monofocal or toric IOLs, which are fixed at the time of implantation, the LAL permits iterative refinement of sphere and cylinder over a series of outpatient visits before the lens is permanently locked with a final light treatment. The technology received FDA approval in 2017 and has since accumulated a growing body of clinical evidence supporting its refractive accuracy in appropriately selected patients.²

In randomized controlled trial data supporting FDA approval, the LAL demonstrated superior uncorrected distance visual acuity and refractive predictability compared with conventional IOLs, with a favorable safety profile.² Ocular inflammation and the requirement for UV-blocking spectacles during the adjustment period are among the procedural considerations associated with the platform.

Why does refractive accuracy matter in premium cataract surgery?

Refractive accuracy following cataract surgery is a key determinant of patient satisfaction, particularly among those selecting premium IOL options with expectations of reduced spectacle dependence.³ Residual refractive error—whether spherical or cylindrical—remains a leading cause of dissatisfaction after otherwise uncomplicated surgery.³ National benchmark data for IOL accuracy are reported through large registry analyses and multicenter studies, against which individual practice performance can be contextualized.

Toric IOL rotation and biometric calculation error represent two primary contributors to suboptimal refractive outcomes with conventional lenses.⁴ The LAL's postoperative adjustability theoretically mitigates both sources of error, provided patients complete the adjustment protocol and tolerate the UV treatment series.

What limitations apply to these single-center, non-peer-reviewed data?

Several limitations apply to these reported figures. The data are drawn from a single practice's internal analysis and have not undergone peer review or independent statistical audit. Patient selection criteria, surgical volume, biometry platform, and surgeon experience are not described in the press release, and any or all of these factors could influence outcomes independent of lens technology. The national average comparators cited by the practice are not fully sourced in the release, and the Doane et al. comparison study could not be independently verified for this report.

Readers should interpret these figures as practice-reported quality data rather than controlled clinical evidence, and await peer-reviewed publication before drawing conclusions about comparative effectiveness.

References
1. Frantz EyeCare. Frantz EyeCare surpasses national averages with Light Adjustable Lens, delivering industry-leading vision outcomes. GlobeNewswire. July 21, 2026. https://www.globenewswire.com/news-release/2026/07/21/3330766/0/en/frantz-eyecare-surpasses-national-averages-with-light-adjustable-lens-delivering-industry-leading-vision-outcomes.html
2. US Food and Drug Administration. Summary of Safety and Effectiveness Data: Light Adjustable Lens (LAL). Premarket Approval P160055. FDA; 2017. https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160055b.pdf
3. Behndig A, Montan P, Stenevi U, Kugelberg M, Lundström M. One million cataract surgeries: Swedish National Cataract Register 1992–2009. J Cataract Refract Surg. 2011;37(8):1539-1545. https://doi.org/10.1016/j.jcrs.2011.03.057
4. Epitropoulos AT, Matossian C, Berdy GJ, Malhotra RP, Potvin R. Effect of tear osmolarity on repeatability and reproducibility of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672-1677. https://doi.org/10.1016/j.jcrs.2015.01.016